当前位置:首页 - 行情中心 - 辰光医疗(920300) - 财务分析 - 现金流量表

辰光医疗

(920300)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金67,672,959.9929,583,306.02152,687,808.39100,196,690.49
  收到的税费返还52,969.852,969.8-10,979.01
  收到其他与经营活动有关的现金1,521,811.74764,186.73,047,327.451,993,054.44
  经营活动现金流入小计69,247,741.5330,400,462.52155,735,135.84102,200,723.94
  购买商品、接受劳务支付的现金28,321,462.7116,390,347.1792,828,207.5371,760,956.97
  支付给职工以及为职工支付的现金29,127,913.8415,987,505.0566,160,101.7148,362,944.22
  支付的各项税费1,987,871.47699,873.983,829,671.733,262,240.16
  支付其他与经营活动有关的现金10,926,982.825,520,092.2321,401,630.3123,675,372.25
  经营活动现金流出小计70,364,230.8438,597,818.43184,219,611.28147,061,513.6
  经营活动产生的现金流量净额-1,116,489.31-8,197,355.91-28,484,475.44-44,860,789.66
二、投资活动产生的现金流量:
  收回投资收到的现金60,000,00016,000,00088,000,00056,000,000
  取得投资收益收到的现金126,820.8419,239.45695,523.34389,185.83
  处置固定资产、无形资产和其他长期资产收回的现金净额--7,100600
  投资活动现金流入小计60,126,820.8416,019,239.4588,702,623.3456,389,785.83
  购建固定资产、无形资产和其他长期资产支付的现金1,164,531.65802,279.318,665,071.375,344,285.86
  投资支付的现金80,000,00036,000,00088,000,00088,000,000
  投资活动现金流出小计81,164,531.6536,802,279.3106,665,071.3793,344,285.86
  投资活动产生的现金流量净额-21,037,710.81-20,783,039.85-17,962,448.03-36,954,500.03
三、筹资活动产生的现金流量:
  取得借款收到的现金46,000,00012,000,000140,250,000100,050,000
  筹资活动现金流入小计46,000,00012,000,000140,250,000100,050,000
  偿还债务支付的现金47,150,0008,500,000122,550,00063,600,000
  分配股利、利润或偿付利息支付的现金2,195,055.651,092,631.524,261,057.233,108,313.57
  支付其他与筹资活动有关的现金1,531,722.5-2,917,771.921,688,302.85
  筹资活动现金流出小计50,876,778.159,592,631.52129,728,829.1568,396,616.42
  筹资活动产生的现金流量净额-4,876,778.152,407,368.4810,521,170.8531,653,383.58
四、汇率变动对现金及现金等价物的影响6,277.7635,072.57182,724.0765,013.24
五、现金及现金等价物净增加额-27,024,700.51-26,537,954.71-35,743,028.55-50,096,892.87
  加:期初现金及现金等价物余额52,529,011.3552,829,011.3588,272,039.988,272,039.9
  期末现金及现金等价物余额25,504,310.8426,291,056.6452,529,011.3538,175,147.03
补充资料:
  净利润-14,817,670.78--60,898,635.5-
  资产减值准备1,394,339.31-22,098,174.01-
  固定资产和投资性房地产折旧5,020,978.06-9,271,791.44-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧5,020,978.06-9,271,791.44-
  无形资产摊销2,522,310.67-6,641,911.58-
  长期待摊费用摊销1,366,055.02-2,036,327.7-
  处置固定资产、无形资产和其他长期资产的损失--72,912.53-
  财务费用2,590,091.06-5,015,933.67-
  投资损失-126,820.84--695,523.34-
  递延所得税-3,736,702.87--7,765,339.44-
  其中:递延所得税资产减少-3,736,702.87--7,765,339.44-
  存货的减少-504,920.57--36,686,009.33-
  经营性应收项目的减少12,373,615.65-12,713,127.94-
  经营性应付项目的增加-6,961,720.31-11,298,857.57-
  不涉及现金收支的投资和筹资活动金额其他项目--128,564.96-
  现金的期末余额25,504,310.84-52,529,011.35-
  减:现金的期初余额52,529,011.35-88,272,039.9-
  现金及现金等价物的净增加额-27,024,700.51--35,743,028.55-
公告日期2025-08-282025-04-292025-04-252024-10-30
审计意见(境内)标准无保留意见
TOP↑